435 related articles for article (PubMed ID: 16318984)
21. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
22. Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease.
Kohm AP; Turley DM; Miller SD
Int Rev Immunol; 2005; 24(5-6):361-92. PubMed ID: 16318987
[TBL] [Abstract][Full Text] [Related]
23. CD11a/ICAM-1 blockade combined with IL-2 targeting therapy causes a paradoxical acceleration of type 1 diabetes.
Brenu EW; Bartley TJ; Wright CM; Hamilton-Williams EE
Immunol Cell Biol; 2017 Oct; 95(9):803-813. PubMed ID: 28611472
[TBL] [Abstract][Full Text] [Related]
24. CD3-specific antibody-induced active tolerance: from bench to bedside.
Chatenoud L
Nat Rev Immunol; 2003 Feb; 3(2):123-32. PubMed ID: 12563296
[TBL] [Abstract][Full Text] [Related]
25. Reestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes.
Maurice Morillon Y; Martin A; Gojanovich G; Wang B; Tisch R
Arch Immunol Ther Exp (Warsz); 2015 Aug; 63(4):239-50. PubMed ID: 25790749
[TBL] [Abstract][Full Text] [Related]
26. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.
Silveira PA; Grey ST
Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840
[TBL] [Abstract][Full Text] [Related]
27. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.
Shekhar C
Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495
[No Abstract] [Full Text] [Related]
28. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development.
Ford MS; Chen W; Wong S; Li C; Vanama R; Elford AR; Asa SL; Ohashi PS; Zhang L
Eur J Immunol; 2007 Aug; 37(8):2234-41. PubMed ID: 17578845
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes.
Wang R; Song L; Han G; Wang J; Chen G; Xu R; Yu M; Qian J; Shen B; Li Y
Scand J Immunol; 2007 Nov; 66(5):515-22. PubMed ID: 17883389
[TBL] [Abstract][Full Text] [Related]
30. Regulation of type 1 diabetes by NKT cells.
Novak J; Griseri T; Beaudoin L; Lehuen A
Int Rev Immunol; 2007; 26(1-2):49-72. PubMed ID: 17454264
[TBL] [Abstract][Full Text] [Related]
31. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
32. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
Boitard C
Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer.
Cameron MJ; Arreaza GA; Waldhauser L; Gauldie J; Delovitch TL
Gene Ther; 2000 Nov; 7(21):1840-6. PubMed ID: 11110416
[TBL] [Abstract][Full Text] [Related]
34. Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes.
Dufour FD; Silveira PA; Baxter AG
J Immunotoxicol; 2008 Apr; 5(2):249-57. PubMed ID: 18569396
[TBL] [Abstract][Full Text] [Related]
35. [Antibodies instead of insulin?].
Anders S; Kühnemund L; Stauch M; Zündorf I; Dingermann T
Pharm Unserer Zeit; 2010 Mar; 39(2):97-8. PubMed ID: 20196056
[No Abstract] [Full Text] [Related]
36. Dendritic cell subsets and type I diabetes: focus upon DC-based therapy.
Lo J; Clare-Salzler MJ
Autoimmun Rev; 2006 Jul; 5(6):419-23. PubMed ID: 16890897
[TBL] [Abstract][Full Text] [Related]
37. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
[TBL] [Abstract][Full Text] [Related]
38. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
39. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
de Jersey J; Snelgrove SL; Palmer SE; Teteris SA; Mullbacher A; Miller JF; Slattery RM
Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1295-300. PubMed ID: 17229843
[TBL] [Abstract][Full Text] [Related]
40. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
